BD (Becton, Dickinson and Company), USA: Medical Devices, Products and Healthcare Technologies
Introduction
Becton, Dickinson and Company, commonly known as BD, is one of the world’s largest pure-play medical technology companies. Headquartered in the United States, BD develops and manufactures medical devices, medication-delivery technologies, connected-care systems, pharmaceutical drug-delivery products, interventional devices, laboratory technologies and other healthcare solutions.
BD has a history spanning more than 125 years and operates globally with more than 60,000 employees. The company says it delivers billions of products each year across healthcare settings.
BD’s products are used by hospitals, clinics, pharmacies, laboratories, pharmaceutical companies, physicians, nurses and other healthcare professionals.
Rather than concentrating on one specialty such as cardiac devices or imaging, BD works across the medication-delivery, patient-safety, medication-management, pharmaceutical, interventional and life-sciences portions of healthcare.
What Does BD Make?
BD’s product portfolio includes:
- Syringes and needles
- Safety needles
- Insulin syringes and pen needles
- IV catheters
- PICC and vascular-access systems
- Central venous catheters
- Drug-delivery devices
- Prefillable syringes
- Self-injection systems
- Infusion and medication-management systems
- Automated medication dispensing systems
- Patient monitoring technologies
- Hemodynamic monitoring
- Blood-collection products
- Specimen-management systems
- Surgical products
- Hernia-repair products
- Infection-prevention products
- Vascular-intervention devices
- Atherectomy systems
- Thrombectomy technologies
- Peripheral vascular stents
- Urology devices
- Urinary catheters
- Incontinence-care products
- Critical-care products
- Endoscopic technologies
- Biopharmaceutical drug-delivery systems
- Laboratory and life-sciences technologies
BD’s current official portfolio spans these product and solution areas, although the company’s organizational structure changed in 2025.
BD’s Five Current Business Segments
Since October 1, 2025, BD has organized its worldwide operations into five segments:
- Medical Essentials
- Connected Care
- BioPharma Systems
- Interventional
- Life Sciences
The reorganization did not change the principal product lines of the businesses, but it changed how BD manages and reports them.
Let’s look at each area in detail.
1. Medical Essentials
Medical Essentials forms one of the foundations of BD’s business.
This area includes everyday medical products that are used repeatedly throughout hospitals, clinics and other healthcare settings.
Major areas include:
- Medication delivery
- IV access
- Specimen management
- Injection products
- Safety products
- Blood-collection technologies
BD says its Medical Essentials business produces billions of devices that support safe medication administration and diagnostic workflows.
2. Syringes
BD is particularly well known for its syringes.
The company manufactures different syringe designs for:
- Medication injection
- Vaccination
- Insulin administration
- Tuberculin applications
- Oral/enteral medication
- Specialty clinical procedures
- Pharmaceutical drug delivery
Its portfolio includes both conventional and safety-engineered syringe systems.
3. Hypodermic Needles
BD also manufactures a large range of hypodermic needles.
These can be used for:
- Vaccination
- Medication injection
- Blood sampling
- Insulin administration
- Anesthesia
- Other clinical procedures
Safety-engineered needle products are designed to help reduce the risk of accidental needlestick injuries among healthcare workers.
4. Insulin Pen Needles
BD develops products used for insulin administration.
Its portfolio includes:
- Pen needles
- Insulin syringes
- Safety pen needles
- Related injection accessories
These products are used by people who require injectable diabetes medications.
BD’s injection portfolio is one of the company’s long-established medical-device businesses.
5. IV Catheters
Intravenous (IV) catheters are another major BD product category.
IV catheters provide access to a patient’s bloodstream so healthcare professionals can administer:
- Medicines
- Fluids
- Blood products
- Nutrition
- Other intravenous therapies
BD produces conventional and safety IV catheters along with advanced vascular-access products. Its 2025 annual report specifically identifies peripheral IV catheters and advanced peripheral catheters among its medication-delivery products.
6. Vascular Access Products
BD has a broad vascular-access portfolio.
It includes technologies such as:
- Peripheral IV catheters
- Midline catheters
- PICC systems
- Central venous catheters
- Port-access products
- Dialysis catheters
- Needle-free connectors
- Extension sets
- Catheter securement
- Disinfection products
These technologies are used to establish and maintain vascular access in hospital patients.
BD’s official filings describe vascular access as an important part of its Medication Delivery Solutions business.
7. BD Nexiva Catheter System
BD Nexiva is one of the company’s vascular-access product families.
It is designed around integrated IV catheter technology and can help healthcare professionals establish peripheral intravenous access.
BD currently features the Nexiva Catheter System among its medical products.
8. Central Venous and PICC Technologies
For patients requiring longer-term vascular access, BD offers technologies involving:
- PICC lines
- Central venous catheters
- Catheter-placement systems
- Securement
- Infection-prevention accessories
These products are used in areas such as intensive care, oncology, long-term medication administration and other hospital treatments.
9. Medication Management
BD’s Connected Care segment includes medication-management technologies.
The objective is not simply to deliver medicine, but to help hospitals manage medication more safely and efficiently.
Technologies in this area include:
- Automated medication dispensing
- Medication inventory management
- Pharmacy automation
- Medication tracking
- Digital medication workflows
- Connected clinical systems
BD identifies Medication Management Solutions as one of the major businesses within Connected Care.
10. BD Pyxis
One of BD’s best-known hospital technologies is BD Pyxis.
Pyxis is a family of automated medication and supply-management systems.
These systems can help hospitals:
- Secure medications
- Control access
- Track medication availability
- Manage inventory
- Support nursing workflows
- Improve medication visibility
BD’s current portfolio includes the BD Pyxis Pro Dispensing Solution, which incorporates enhanced capacity, security, durability and AI-powered analytics.
11. BD Pyxis Pro
The BD Pyxis Pro Dispensing Solution represents the newer generation of BD’s automated medication-management technology.
It is designed to provide hospitals with greater visibility and control over medication availability and dispensing workflows.
BD currently describes Pyxis Pro as a next-generation automated dispensing solution with AI-powered analytics.
12. Advanced Patient Monitoring
BD’s Connected Care business also includes advanced patient monitoring.
The company develops technologies designed to help clinicians monitor physiological parameters in critically ill patients.
Products can support monitoring of:
- Blood pressure
- Cardiac parameters
- Hemodynamic status
- Other physiological measurements
BD currently highlights its HemoSphere monitoring portfolio in this area.
13. HemoSphere Alta Monitor
The HemoSphere Alta Monitor is one of BD’s current advanced patient-monitoring products.
It is designed to help clinicians monitor hemodynamic information and identify changes in critically ill patients.
BD describes HemoSphere Alta as a system intended to help detect hemodynamic instability before it occurs.
14. VitaWave Plus
Another BD monitoring technology is the VitaWave Plus System.
It provides noninvasive, continuous blood-pressure monitoring that can connect with bedside monitoring workflows.
This type of technology can provide clinicians with continuous physiological information without requiring an invasive arterial line in appropriate applications.
15. BioPharma Systems
BD’s BioPharma Systems business focuses on technologies used by pharmaceutical and biotechnology companies.
This is different from simply manufacturing hospital medical devices.
BD develops components and systems that can help pharmaceutical companies package and administer injectable medicines.
Its portfolio includes:
- Prefillable syringes
- Drug-delivery systems
- Self-injection devices
- Safety and shielding systems
- Plunger stoppers
- Backstops
- Plunger rods
- Combination-product technologies
BD says its Pharmaceutical Systems business has more than 60 years of drug-delivery experience.
16. Prefillable Syringe Systems
BD manufactures prefillable syringe systems for pharmaceutical and biotechnology companies.
A prefillable syringe can be supplied to a drug manufacturer as part of a ready-to-fill or ready-to-use drug-delivery system.
These systems can be particularly relevant to:
- Biologic medicines
- Vaccines
- Diabetes therapies
- Oncology drugs
- Autoimmune treatments
- Other injectable medicines
BD says its drug-delivery business manufactures more than 3 billion prefillable syringes annually.
17. Self-Injection Systems
BD also develops systems that allow certain medicines to be administered through self-injection.
These can include:
- Autoinjector-related technologies
- Pen-based delivery
- Prefillable systems
- Drug-device combination technologies
The objective is to make injectable therapies easier and more convenient to administer outside traditional hospital environments.
18. Pharmaceutical Packaging Components
BD’s pharmaceutical systems portfolio extends beyond the syringe itself.
The company also produces components such as:
- Plunger stoppers
- Plunger rods
- Backstops
- Needle-shielding components
- Safety systems
These components are designed to work together with pharmaceutical drug-delivery systems.
19. Specimen Management
BD’s Medical Essentials portfolio also includes specimen-management products.
These products help healthcare professionals collect, transport and manage biological specimens for laboratory testing.
They can include systems for:
- Blood collection
- Urine collection
- Swab collection
- Sample transport
- Specimen containers
- Collection accessories
Specimen Management is one of the business units now included within BD’s Medical Essentials segment.
20. Blood Collection Products
BD develops products used for blood collection.
These can include:
- Blood-collection tubes
- Collection needles
- Safety devices
- Blood-collection systems
- Accessories
Proper specimen collection is an important part of laboratory diagnostics because the quality of a sample can influence subsequent testing.
21. Infection Prevention
BD also manufactures products designed to support infection-prevention practices.
Examples include:
- Skin antiseptics
- Catheter-disinfection products
- Surgical preparation products
- Antimicrobial products
- Protective technologies
One of its best-known products is BD ChloraPrep, a chlorhexidine-based skin-preparation product used for certain clinical procedures. BD currently lists ChloraPrep among its featured products.
22. BD ChloraPrep
BD ChloraPrep is designed for skin antisepsis before certain invasive medical procedures.
Skin preparation is an important step in reducing the risk of microorganisms entering the body during procedures.
Specific formulations and approved uses vary by country.
23. Sharps Disposal
BD also produces sharps-disposal systems.
These containers are designed for safe disposal of items such as:
- Needles
- Syringes
- Lancets
- Other sharp medical instruments
Proper sharps management helps reduce accidental injuries and occupational exposure.
24. Interventional Medicine
BD’s Interventional business covers technologies used in minimally invasive procedures.
This includes products for:
- Peripheral vascular intervention
- Surgery
- Urology
- Critical care
- Oncology
- Vascular access
- Hernia repair
BD’s current Interventional segment contains Peripheral Intervention, Urology & Critical Care and Surgery businesses.
25. Peripheral Vascular Devices
BD manufactures technologies used to treat certain peripheral vascular conditions.
Its portfolio includes:
- PTA balloon catheters
- Drug-coated balloons
- Peripheral stents
- Stent grafts
- Atherectomy systems
- Thrombectomy devices
- Vascular grafts
- Inferior vena cava filters
- Dialysis-access technologies
BD’s 2025 annual filing lists these among its Peripheral Intervention products.
26. Atherectomy Systems
Atherectomy is a minimally invasive technique used to remove or modify plaque inside blood vessels.
BD’s portfolio includes the Rotarex Rotational Excisional Atherectomy System.
The system is designed to mechanically remove certain obstructive material from blood vessels during appropriate peripheral vascular procedures.
27. Thrombectomy Technologies
BD also develops technologies for removing blood clots from vessels.
Thrombectomy systems may be used in selected vascular conditions where mechanical removal of thrombus is clinically appropriate.
The specific device and technique depend on the affected vessel, disease and physician assessment.
28. Surgical Products
BD’s Interventional business includes a broad range of surgical products.
These include technologies for:
- Hernia repair
- Soft-tissue repair
- Biosurgery
- Surgical infection prevention
- Wound-related procedures
- Tissue reconstruction
BD’s official filing specifically lists hernia and soft-tissue repair, biological and bioresorbable grafts, biosurgery and other surgical products.
29. Hernia Repair Products
BD develops products used in hernia repair surgery.
These can include surgical mesh and related soft-tissue repair technologies.
One example is Phasix Mesh, which BD currently describes as a fully resorbable implant for soft-tissue reconstruction.
The appropriate mesh or repair method depends on the type of hernia, patient factors and surgeon preference.
30. Urology Products
Urology is another major part of BD’s Interventional portfolio.
Its products address areas including:
- Urinary catheterization
- Urinary drainage
- Kidney and urinary-tract procedures
- Acute urology
- Incontinence management
- Critical-care urinary care
BD’s current product portfolio includes urinary catheters and related urological technologies.
31. Foley Catheters
BD manufactures Foley urinary catheters.
These are commonly used to drain urine from the bladder when a patient cannot urinate normally or when controlled urinary drainage is clinically required.
The Bardex I.C. Foley Catheter with Bactiguard coating is one of BD’s current featured products.
32. Intermittent Catheters
BD also produces intermittent catheterization products.
The Magic3 Go intermittent hydrophilic catheter is one example.
These products are designed for intermittent urinary catheterization and are available in configurations intended to improve portability and ease of use.
33. PureWick External Catheter
PureWick is another well-known BD urinary-care technology.
Unlike a traditional indwelling urinary catheter, an external catheter system is designed to manage urine without placing a catheter inside the bladder.
BD currently offers the PureWick portfolio for female and male external catheter options and describes it as a non-invasive approach to urine-output management.
34. Critical Care Products
BD also develops technologies used in critical-care environments.
These include:
- Hemodynamic monitoring
- Vascular access
- Acute dialysis access
- Urinary management
- Patient-monitoring technologies
- Critical-care accessories
Such products can be used in intensive-care units and other acute-care environments.
35. Endoscopy Technologies
BD has also expanded into single-use endoscopy.
The company currently lists BD Aptra Single-Use Digital Flexible Endoscope Systems.
BD describes Aptra as a system offering two scopes designed to streamline operating-room workflow.
Single-use endoscopy can help hospitals reduce some of the cleaning, sterilization and reprocessing requirements associated with reusable scopes.
36. Home Healthcare Technologies
BD is increasingly developing technologies that can move certain aspects of care outside traditional hospitals.
Examples include:
- Home drug delivery
- Self-injection
- Home urinary care
- Portable urinary collection
- Wearable drug-delivery technologies
BD’s recent sustainability report identifies home drug delivery and home urinary incontinence as areas of innovation.
37. Connected Healthcare and AI
BD is also investing in connected healthcare.
Its current technology strategy includes:
- Automation
- Artificial intelligence
- Data analytics
- Connected devices
- Medication-management software
- Smart patient monitoring
- Healthcare workflow technologies
BD’s innovation program highlights smart connected care, AI informatics and robotics as areas of development.
38. BD Incada Connected Care Platform
BD Incada is part of BD’s newer connected-care approach.
The platform is designed to help healthcare organizations turn data from connected systems into information that can support operational and clinical decision-making.
BD currently describes Incada as a connected-care platform focused on activating healthcare data.
39. BD’s Role in Pharmaceutical Manufacturing
BD does not only sell devices directly to hospitals.
Its drug-delivery systems are also used by pharmaceutical and biotechnology companies.
A pharmaceutical manufacturer can use BD components when developing injectable products, including:
- Prefillable syringes
- Self-injection systems
- Safety systems
- Elastomer components
- Combination-product technologies
This makes BD an important supplier within the pharmaceutical manufacturing ecosystem.
40. Life Sciences and Diagnostics – An Important Current Update
BD historically had a major Life Sciences business covering areas such as diagnostics and biosciences.
However, there has been a significant recent corporate change.
BD’s Biosciences and Diagnostic Solutions businesses combined with Waters Corporation, creating a new life-sciences and diagnostics business. BD’s current website states that BD Diagnostic Solutions is now Waters Advanced Diagnostics.
Therefore, older articles that describe every BD laboratory diagnostic and bioscience product as part of the current BD portfolio should be checked carefully.
BD continues to report a Life Sciences segment during the transition, but the corporate portfolio has changed.
BD’s Current Business Structure
Segment Main Areas Medical Essentials Medication Delivery, Specimen Management Connected Care Medication Management, Advanced Patient Monitoring BioPharma Systems Pharmaceutical drug-delivery systems Interventional Peripheral Intervention, Urology & Critical Care, Surgery Life Sciences Remaining life-science activities during current corporate transition
This five-segment structure became effective October 1, 2025.
Major BD Products at a Glance
Product / Brand Main Use BD Syringes Medication and injection delivery BD Safety Needles Safer injections BD Nexiva IV access BD Pyxis Automated medication management BD HemoSphere Advanced patient monitoring BD VitaWave Plus Continuous noninvasive BP monitoring BD ChloraPrep Skin antisepsis BD Phasix Mesh Soft-tissue/hernia repair Rotarex Peripheral atherectomy PureWick External urine management Magic3 Go Intermittent catheterization Bardex I.C. Foley urinary catheter BD Aptra Single-use flexible endoscopy BD Hypak Prefillable pharmaceutical syringe systems
These products represent only a portion of BD’s broader portfolio.
BD’s Financial Scale
BD generated approximately $21.8 billion in fiscal 2025 revenue under its previous three-segment reporting structure.
The FY2025 revenue breakdown was approximately:
- BD Medical: $11.5 billion
- BD Life Sciences: $5.2 billion
- BD Interventional: $5.2 billion
The company subsequently reorganized into five segments effective October 1, 2025.
This scale demonstrates how broadly BD’s products are embedded across healthcare systems.
BD’s Global Reach
BD operates internationally and supplies healthcare products across a wide range of markets.
Its customers include:
- Hospitals
- Clinics
- Laboratories
- Pharmacies
- Pharmaceutical companies
- Biotechnology companies
- Government healthcare organizations
- Research institutions
- Healthcare professionals
- Home-care users
BD says it operates globally with more than 60,000 employees and delivers billions of products annually.
BD in India
BD has a presence in India and supplies medical technologies used across hospitals, laboratories, pharmaceutical manufacturing and other healthcare environments.
Its product areas relevant to the Indian market include:
- Syringes
- Needles
- IV catheters
- Vascular-access products
- Medication-management technologies
- Surgical products
- Urology products
- Diagnostic and laboratory-related technologies
- Pharmaceutical drug-delivery systems
Availability of individual products can vary according to Indian regulatory approvals, product registration and commercial distribution.
Why BD Is Important in Healthcare
BD is particularly important because many of its products are used during basic, everyday healthcare procedures.
A hospital may use BD technology when:
A patient arrives → blood/specimen is collected → IV access is established → medicine is administered → medication is managed → patient is monitored → surgery or intervention is performed → urinary care is provided → samples are processed.
This means BD products can be involved in multiple stages of patient care even when the patient may not recognize the BD brand.
Frequently Asked Questions
1. What is BD?
BD stands for Becton, Dickinson and Company. It is a U.S.-based global medical technology company that develops medical devices, medication-delivery systems, connected-care technologies, pharmaceutical drug-delivery systems and interventional products.
2. What does BD make?
BD makes syringes, needles, IV catheters, vascular-access devices, medication-management systems, patient-monitoring technologies, pharmaceutical drug-delivery systems, surgical products, vascular devices, urology products and many other healthcare technologies.
3. Does BD make syringes?
Yes. Syringes and hypodermic needles are among BD’s long-established medical products.
4. Does BD make IV cannulas?
Yes. BD manufactures peripheral IV catheters and other vascular-access products.
5. What is BD Pyxis?
BD Pyxis is a family of automated medication and supply-management technologies used by healthcare organizations. The newer Pyxis Pro system adds enhanced capacity, security and AI-powered analytics.
6. What is BD HemoSphere?
HemoSphere is a BD advanced patient-monitoring platform used for hemodynamic monitoring. BD’s current portfolio includes the HemoSphere Alta Monitor.
7. Does BD make urinary catheters?
Yes. BD produces Foley catheters, intermittent catheters and other urinary-care products. Its portfolio includes Bardex I.C. and Magic3 Go.
8. What is PureWick?
PureWick is BD’s external catheter portfolio for urine-output management. It provides female and male external catheter options.
9. Does BD make hernia mesh?
Yes. BD’s surgical portfolio includes hernia and soft-tissue repair products. Phasix Mesh is one example of a resorbable soft-tissue reconstruction product.
10. Does BD make products for pharmaceutical companies?
Yes. BD BioPharma Systems develops prefillable syringes, self-injection systems, safety systems and other drug-delivery components for pharmaceutical and biotechnology companies.
11. Is BD still a diagnostics company?
BD historically had substantial diagnostics and biosciences businesses, but there has been a major corporate change. BD’s Biosciences and Diagnostic Solutions businesses have combined with Waters, and BD’s website now identifies BD Diagnostic Solutions as Waters Advanced Diagnostics.
12. How many business segments does BD currently have?
Since October 1, 2025, BD has five worldwide business segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences.
Conclusion
BD (Becton, Dickinson and Company), USA is one of the world’s major medical technology companies, with products used throughout hospitals, clinics, pharmacies, pharmaceutical manufacturing facilities and home healthcare.
Its portfolio ranges from everyday healthcare essentials such as syringes, needles and IV catheters to sophisticated technologies including automated medication dispensing, advanced hemodynamic monitoring, vascular-intervention devices, surgical products, urology systems and pharmaceutical drug-delivery platforms.
BD’s importance comes partly from the enormous number of healthcare procedures in which its products can be involved. Medication administration, vascular access, specimen collection, surgery, patient monitoring and urinary care are all areas where BD technologies can play a role.
The company is also moving toward more connected healthcare through automation, AI, analytics and smart medical devices, while expanding technologies for home care and pharmaceutical drug delivery.
With its broad medical-device portfolio and global reach, BD remains a major part of the infrastructure that supports modern healthcare delivery.
